206 related articles for article (PubMed ID: 38180104)
21. Integrative analyses of ferroptosis and immune related biomarkers and the osteosarcoma associated mechanisms.
Li G; Lei J; Xu D; Yu W; Bai J; Wu G
Sci Rep; 2023 Apr; 13(1):5770. PubMed ID: 37031292
[TBL] [Abstract][Full Text] [Related]
22. Identification of ATG7 as a Regulator of Proferroptosis and Oxidative Stress in Osteosarcoma.
Jiang R; He S; Gong H; Wang Y; Wei W; Chen J; Hu J; Ye C; LiuHuang S; Jin S; Wei H; Xu W; Xiao J
Oxid Med Cell Longev; 2022; 2022():8441676. PubMed ID: 36254233
[TBL] [Abstract][Full Text] [Related]
23. A novel stratification framework based on anoikis-related genes for predicting the prognosis in patients with osteosarcoma.
Zhang X; Wen Z; Wang Q; Ren L; Zhao S
Front Immunol; 2023; 14():1199869. PubMed ID: 37575253
[TBL] [Abstract][Full Text] [Related]
24. Verification of Ferroptosis Subcluster-Associated Genes Related to Osteosarcoma and Exploration of Immune Targeted Therapy.
Jiang M; Jike Y; Gan F; Li J; Hu Y; Xie M; Liu K; Qin W; Bo Z
Oxid Med Cell Longev; 2022; 2022():9942014. PubMed ID: 36211822
[TBL] [Abstract][Full Text] [Related]
25. Development of a novel vasculogenic mimicry-associated gene signature for the prognostic assessment of osteosarcoma patients.
Yan L; Li R; Li D; Zhu Y; Lv Z; Wang B
Clin Transl Oncol; 2023 Dec; 25(12):3501-3518. PubMed ID: 37219824
[TBL] [Abstract][Full Text] [Related]
26. The hexosamine biosynthesis pathway-related gene signature correlates with immune infiltration and predicts prognosis of patients with osteosarcoma.
Su Z; Wang C; Pan R; Li H; Chen J; Tan J; Tian X; Lin T; Shen J
Front Immunol; 2022; 13():1028263. PubMed ID: 36275679
[TBL] [Abstract][Full Text] [Related]
27. Anoikis patterns exhibit distinct prognostic and immune landscapes in Osteosarcoma.
Zhang Z; Zhu Z; Fu J; Liu X; Mi Z; Tao H; Fan H
Int Immunopharmacol; 2023 Feb; 115():109684. PubMed ID: 36630752
[TBL] [Abstract][Full Text] [Related]
28. The prognostic value and immune landscapes of m1A/m5C/m6A-associated lncRNA signature in osteosarcoma.
Wu ZY; Shi ZY
Eur Rev Med Pharmacol Sci; 2022 Aug; 26(16):5868-5883. PubMed ID: 36066162
[TBL] [Abstract][Full Text] [Related]
29. Signature constructed by glycolysis-immune-related genes can predict the prognosis of osteosarcoma patients.
Tian K; Qi W; Yan Q; Lv M; Song D
Invest New Drugs; 2022 Aug; 40(4):818-830. PubMed ID: 35435626
[TBL] [Abstract][Full Text] [Related]
30. Machine learning and experimental validation to construct a metastasis-related gene signature and ceRNA network for predicting osteosarcoma prognosis.
Liao Y; Liu Q; Xiao C; Zhou J
J Orthop Surg Res; 2022 Dec; 17(1):516. PubMed ID: 36457129
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive analysis of prognostic tumor microenvironment-related genes in osteosarcoma patients.
Hu C; Liu C; Tian S; Wang Y; Shen R; Rao H; Li J; Yang X; Chen B; Ye L
BMC Cancer; 2020 Aug; 20(1):814. PubMed ID: 32854645
[TBL] [Abstract][Full Text] [Related]
32. Comprehensive analysis of immune-related gene signature based on ssGSEA algorithms in the prognosis and immune landscape of hepatocellular carcinoma.
Wang L; Wang L; He P
Front Genet; 2022; 13():1064432. PubMed ID: 36568383
[No Abstract] [Full Text] [Related]
33. Single-Cell RNA Sequencing Pro-angiogenic Macrophage Profiles Reveal Novel Prognostic Biomarkers and Therapeutic Targets for Osteosarcoma.
Yi C; Li Z; Zhao Q; Gong D; Zhao S; Chen Z; Cheng C; Bian E; Tian D
Biochem Genet; 2024 Apr; 62(2):1325-1346. PubMed ID: 37603193
[TBL] [Abstract][Full Text] [Related]
34. Identification of cuproptosis-related lncRNA prognostic signature for osteosarcoma.
Liu B; Liu Z; Feng C; Li C; Zhang H; Li Z; Tu C; He S
Front Endocrinol (Lausanne); 2022; 13():987942. PubMed ID: 36313774
[TBL] [Abstract][Full Text] [Related]
35. Molecular characterization of Golgi apparatus-related genes indicates prognosis and immune infiltration in osteosarcoma.
Zhang J; Liu J; Ding R; Miao X; Deng J; Zhao X; Wu T; Cheng X
Aging (Albany NY); 2024 Mar; 16(6):5249-5263. PubMed ID: 38460960
[TBL] [Abstract][Full Text] [Related]
36. Identification and validation of a dysregulated TME-related gene signature for predicting prognosis, and immunological properties in bladder cancer.
Shen C; Chai W; Han J; Zhang Z; Liu X; Yang S; Wang Y; Wang D; Wan F; Fan Z; Hu H
Front Immunol; 2023; 14():1213947. PubMed ID: 37965307
[TBL] [Abstract][Full Text] [Related]
37. Comprehensive analysis of copper-metabolism-related genes about prognosis and immune microenvironment in osteosarcoma.
Lin Z; He Y; Wu Z; Yuan Y; Li X; Luo W
Sci Rep; 2023 Sep; 13(1):15059. PubMed ID: 37700003
[TBL] [Abstract][Full Text] [Related]
38. Dissecting the effect of sphingolipid metabolism gene in progression and microenvironment of osteosarcoma to develop a prognostic signature.
Zhong Y; Zhang Y; Wei S; Chen J; Zhong C; Cai W; Jin W; Peng H
Front Endocrinol (Lausanne); 2022; 13():1030655. PubMed ID: 36313783
[TBL] [Abstract][Full Text] [Related]
39. Establishment of an Autophagy-Related Clinical Prognosis Model for Predicting the Overall Survival of Osteosarcoma.
Li J; Tang X; Du Y; Dong J; Zhao Z; Hu H; Song T; Guo J; Wang Y; Xu T; Shao C; Sheng Y; Xi Y
Biomed Res Int; 2021; 2021():5428425. PubMed ID: 34604383
[TBL] [Abstract][Full Text] [Related]
40. A novel risk score model based on eight genes and a nomogram for predicting overall survival of patients with osteosarcoma.
Wu G; Zhang M
BMC Cancer; 2020 May; 20(1):456. PubMed ID: 32448271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]